Teikoku Pharma granted FDA Fast Track designation for TPU-006, a novel 4-day dexmedetomidine transdermal system for postoperative pain management. News release. June 21, 2023.

Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain [Abstract]. https://pubmed.ncbi.nlm.nih.gov/15563741/ Lidocaine 5% patch for ...

A study published in Medical Cannabis and Cannabinoids examined the treatment of diabetic peripheral neuropathy (DPN) using medical cannabis transdermal patches. DPN is a neurological disorder caused ...

Transdermal lidocaine 5% patch should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C) for shorter periods ...

Overview: Transdermal estradiol is available as a patch, gel, or spray that is applied to the skin to increase estrogen levels. It is used after menopause to prevent osteoporosis or to reduce ...

Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Transdermal Skin Patches Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...